ProfileGDS4718 / 223910_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 79% 77% 64% 80% 79% 63% 66% 77% 79% 79% 78% 75% 73% 66% 69% 78% 75% 71% 74% 81% 80% 78% 78% 78% 79% 65% 77% 65% 76% 67% 78% 65% 79% 79% 72% 71% 72% 77% 76% 53% 77% 71% 67% 63% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.7834279
GSM549102patient 115, normal, homogenized [OPG study]7.4712677
GSM549104patient 119, normal, homogenized [OPG study]6.4130664
GSM549108patient 138, normal, homogenized [OPG study]7.6959180
GSM549119patient 077, normal, homogenized [OPG study]7.6922879
GSM549133patient 032, cancer, homogenized [OPG study]6.3252263
GSM549139patient 042, cancer, homogenized [OPG study]6.5853866
GSM549099patient 107, normal, homogenized [OPG study]7.4896677
GSM549109patient 139, normal, homogenized [OPG study]7.6649879
GSM549110patient 046, normal, homogenized [OPG study]7.7264179
GSM549114patient 063, normal, homogenized [OPG study]7.6691778
GSM549122patient 082, normal, homogenized [OPG study]7.345575
GSM549134patient 033, cancer, homogenized [OPG study]7.102273
GSM549136patient 036, cancer, homogenized [OPG study]6.5757966
GSM549140patient 044, cancer, homogenized [OPG study]6.7882469
GSM549111patient 047, normal, homogenized [OPG study]7.6546678
GSM549113patient 057, normal, homogenized [OPG study]7.3571975
GSM549132patient 031, cancer, homogenized [OPG study]6.9859871
GSM549137patient 038, cancer, homogenized [OPG study]7.2314374
GSM549142patient 047, cancer, homogenized [OPG study]7.706681
GSM549100patient 110, normal, homogenized [OPG study]7.7913880
GSM549107patient 135, normal, homogenized [OPG study]7.6355178
GSM549115patient 068, normal, homogenized [OPG study]7.7350178
GSM549116patient 072, normal, homogenized [OPG study]7.6774178
GSM549120patient 078, normal, homogenized [OPG study]7.7892679
GSM549131patient 030, cancer, homogenized [OPG study]6.5194465
GSM549118patient 074, normal, homogenized [OPG study]7.5786277
GSM549129patient 027, cancer, homogenized [OPG study]6.4867665
GSM549123patient 088, normal, homogenized [OPG study]7.4097376
GSM549124patient 006, cancer, homogenized [OPG study]6.6124867
GSM549126patient 015, cancer, homogenized [OPG study]7.6438178
GSM549128patient 025, cancer, homogenized [OPG study]6.4887365
GSM549103patient 117, normal, homogenized [OPG study]7.5747879
GSM549117patient 073, normal, homogenized [OPG study]7.7906879
GSM549138patient 041, cancer, homogenized [OPG study]7.1311172
GSM549141patient 045, cancer, homogenized [OPG study]7.0206471
GSM549130patient 028, cancer, homogenized [OPG study]7.015772
GSM549101patient 111, normal, homogenized [OPG study]7.5344577
GSM549105patient 128, normal, homogenized [OPG study]7.4432876
GSM549106patient 134, normal, homogenized [OPG study]5.6150153
GSM549112patient 048, normal, homogenized [OPG study]7.4932577
GSM549125patient 011, cancer, homogenized [OPG study]6.9642171
GSM549127patient 024, cancer, homogenized [OPG study]6.725967
GSM549135patient 035, cancer, homogenized [OPG study]6.3566663